Sage Therapeutics, Inc.·4

Apr 11, 4:09 PM ET

Quirk Michael C. 4

4 · Sage Therapeutics, Inc. · Filed Apr 11, 2025

Insider Transaction Report

Form 4
Period: 2025-04-10
Quirk Michael C.
See Remarks
Transactions
  • Award

    Common Stock

    2025-04-10+93330,041 total
  • Award

    Common Stock

    2025-04-10+1,26930,998 total
  • Tax Payment

    Common Stock

    2025-04-10$6.91/sh312$2,15629,729 total
  • Tax Payment

    Common Stock

    2025-04-10$6.91/sh424$2,93030,574 total
Footnotes (2)
  • [F1]On February 11, 2022, the reporting person was granted Performance Restricted Stock Units (PSUs) to acquire a total of 2,666 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 933 shares.
  • [F2]On October 3, 2022, the reporting person was granted PSUs to acquire a total of 3,625 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on April 10, 2025, resulting in the vesting of the PSUs as to 1,269 shares.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY